Relmada Therapeutics Provides Corporate Update and Reports First Quarter 2021 Financial Results

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 9/8/2026

1. IONQ
2. IONS
3. AZN
4. SPY
5. ROIV
6. ORCL
7. AAPL
8. HOOD
9. NVDA
10. USO

Go back to Relmada Therapeutics Provides Corporate Update and Reports First Quarter 2021 Financial Results
(NASDAQ: RLMD) Delayed: 4.28 -0.15 (3.39%)
Previous Close $4.43    52 Week High $4.10 
Open $4.40    52 Week Low $0.87 
Day High $4.43    P/E N/A 
Day Low $4.20    EPS $0.00 
Volume 433,396